Cargando…
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
Adenoviruses (Ad) are commonly used both experimentally and clinically, including oncolytic virotherapy applications. In the clinical area, efficacy is frequently hampered by the high rates of neutralizing immunity, estimated as high as 90% in some populations that promote vector clearance and limit...
Autores principales: | Uusi-Kerttula, Hanni, Hulin-Curtis, Sarah, Davies, James, Parker, Alan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664994/ https://www.ncbi.nlm.nih.gov/pubmed/26610547 http://dx.doi.org/10.3390/v7112923 |
Ejemplares similares
-
Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2016) -
Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018) -
Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010) -
Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023) -
Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020)